Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed, 59 citations in OpenAlex.

1. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment.Molecular psychiatry · 2009
   Trial
2. Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.Molecular psychiatry · 2005
   Trial
3. Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.CNS drugs · 2016
   Review
4. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels.Biological psychiatry · 2010
   Article
5. Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.The American journal of gastroenterology · 2008
   Article
6. The practical management of treatment failure in chronic hepatitis C: a summary of current research and management options for refractory patients.Gastroenterology & hepatology · 2007
   Article
7. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.Drugs · 2006
   Review
8. Comparison of the prevalence of psychiatric co-morbidities in hepatitis C patients and hepatitis B patients in Saudi Arabia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
   Article

Corrections and comments

• Comment on
  Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.1999
• Comment on
  Paroxetine for the prevention of depression induced by high-dose interferon alfa.2001
• Comment on
  Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?2001

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as